Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: The women's health initiative calcium plus vitamin D clinical trial

Amy E. Millen, Jean Wactawski-Wende, Mary Pettinger, Michal L. Melamed, Frances A. Tylavsky, Simin Liu, John Robbins, Andrea Z. Lacroix, Meryl S. Leboff, Rebecca D. Jackson

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Background: It is unclear how well surrogate markers for vitamin D exposure (eg, oral intake of vitamin D and estimates of sunlight exposure), with and without consideration of other potential predictors of 25-hydroxyvitamin D [25(OH)D] concentrations, similarly rank individuals with respect to 25(OH)D blood concentrations. Objective: The objective was to determine how much variation in serum 25(OH)D concentrations (nmol/L) could be explained by a predictive model with the use of different vitamin D surrogate markers (latitude of residence, mean annual regional solar irradiance estimates, and oral sources) and other individual characteristics that might influence vitamin D status. Design: A random sample of 3055 postmenopausal women (aged 50-70 y) participating in 3 nested case-control studies of the Women's Health Initiative Calcium plus Vitamin D Clinical Trial was used. Serum 25(OH)D values, assessed at year 1 (1995-2000), and potential predictors of 25(OH)D concentrations, assessed at year 1 or Women's Health Initiative baseline (1993-1998), were used. Results: More than half of the women (57.1%) had deficient (<50 nmol/L) concentrations of 25(OH)D. Distributions of 25(OH)D concentrations by level of latitude of residence, mean annual regional solar irradiance, and intake of vitamin D varied considerably. The predictive model for 25(OH)D explained 21% of the variation in 25(OH)D concentrations. After adjustment for month of blood draw, breast cancer status, colorectal cancer status, fracture status, participation in the hormone therapy trial, and randomization to the dietary modification trial, the predictive model included total vitamin D intake from foods and supplements, waist circumference, recreational physical activity, race-ethnicity, regional solar irradiance, and age. Conclusions: Surrogate markers for 25(OH)D concentrations, although somewhat correlated, do not adequately reflect serum vitamin D measures. These markers and predictive models of blood 25(OH)D concentrations should not be given as much weight in epidemiologic studies of cancer risk.

Original languageEnglish (US)
Pages (from-to)1324-1335
Number of pages12
JournalAmerican Journal of Clinical Nutrition
Volume91
Issue number5
DOIs
StatePublished - May 1 2010

Fingerprint

Women's Health
Vitamin D
Clinical Trials
Calcium
Serum
Biomarkers
Diet Therapy
25-hydroxyvitamin D
Sunlight
Waist Circumference
Random Allocation
Dietary Supplements
Case-Control Studies
Epidemiologic Studies
Colorectal Neoplasms
Hormones
Exercise
Breast Neoplasms
Weights and Measures

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women : The women's health initiative calcium plus vitamin D clinical trial. / Millen, Amy E.; Wactawski-Wende, Jean; Pettinger, Mary; Melamed, Michal L.; Tylavsky, Frances A.; Liu, Simin; Robbins, John; Lacroix, Andrea Z.; Leboff, Meryl S.; Jackson, Rebecca D.

In: American Journal of Clinical Nutrition, Vol. 91, No. 5, 01.05.2010, p. 1324-1335.

Research output: Contribution to journalArticle

Millen, AE, Wactawski-Wende, J, Pettinger, M, Melamed, ML, Tylavsky, FA, Liu, S, Robbins, J, Lacroix, AZ, Leboff, MS & Jackson, RD 2010, 'Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: The women's health initiative calcium plus vitamin D clinical trial', American Journal of Clinical Nutrition, vol. 91, no. 5, pp. 1324-1335. https://doi.org/10.3945/ajcn.2009.28908
Millen, Amy E. ; Wactawski-Wende, Jean ; Pettinger, Mary ; Melamed, Michal L. ; Tylavsky, Frances A. ; Liu, Simin ; Robbins, John ; Lacroix, Andrea Z. ; Leboff, Meryl S. ; Jackson, Rebecca D. / Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women : The women's health initiative calcium plus vitamin D clinical trial. In: American Journal of Clinical Nutrition. 2010 ; Vol. 91, No. 5. pp. 1324-1335.
@article{ce2af8aa87b9481d95d74b460c4fe646,
title = "Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: The women's health initiative calcium plus vitamin D clinical trial",
abstract = "Background: It is unclear how well surrogate markers for vitamin D exposure (eg, oral intake of vitamin D and estimates of sunlight exposure), with and without consideration of other potential predictors of 25-hydroxyvitamin D [25(OH)D] concentrations, similarly rank individuals with respect to 25(OH)D blood concentrations. Objective: The objective was to determine how much variation in serum 25(OH)D concentrations (nmol/L) could be explained by a predictive model with the use of different vitamin D surrogate markers (latitude of residence, mean annual regional solar irradiance estimates, and oral sources) and other individual characteristics that might influence vitamin D status. Design: A random sample of 3055 postmenopausal women (aged 50-70 y) participating in 3 nested case-control studies of the Women's Health Initiative Calcium plus Vitamin D Clinical Trial was used. Serum 25(OH)D values, assessed at year 1 (1995-2000), and potential predictors of 25(OH)D concentrations, assessed at year 1 or Women's Health Initiative baseline (1993-1998), were used. Results: More than half of the women (57.1{\%}) had deficient (<50 nmol/L) concentrations of 25(OH)D. Distributions of 25(OH)D concentrations by level of latitude of residence, mean annual regional solar irradiance, and intake of vitamin D varied considerably. The predictive model for 25(OH)D explained 21{\%} of the variation in 25(OH)D concentrations. After adjustment for month of blood draw, breast cancer status, colorectal cancer status, fracture status, participation in the hormone therapy trial, and randomization to the dietary modification trial, the predictive model included total vitamin D intake from foods and supplements, waist circumference, recreational physical activity, race-ethnicity, regional solar irradiance, and age. Conclusions: Surrogate markers for 25(OH)D concentrations, although somewhat correlated, do not adequately reflect serum vitamin D measures. These markers and predictive models of blood 25(OH)D concentrations should not be given as much weight in epidemiologic studies of cancer risk.",
author = "Millen, {Amy E.} and Jean Wactawski-Wende and Mary Pettinger and Melamed, {Michal L.} and Tylavsky, {Frances A.} and Simin Liu and John Robbins and Lacroix, {Andrea Z.} and Leboff, {Meryl S.} and Jackson, {Rebecca D.}",
year = "2010",
month = "5",
day = "1",
doi = "10.3945/ajcn.2009.28908",
language = "English (US)",
volume = "91",
pages = "1324--1335",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "5",

}

TY - JOUR

T1 - Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women

T2 - The women's health initiative calcium plus vitamin D clinical trial

AU - Millen, Amy E.

AU - Wactawski-Wende, Jean

AU - Pettinger, Mary

AU - Melamed, Michal L.

AU - Tylavsky, Frances A.

AU - Liu, Simin

AU - Robbins, John

AU - Lacroix, Andrea Z.

AU - Leboff, Meryl S.

AU - Jackson, Rebecca D.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Background: It is unclear how well surrogate markers for vitamin D exposure (eg, oral intake of vitamin D and estimates of sunlight exposure), with and without consideration of other potential predictors of 25-hydroxyvitamin D [25(OH)D] concentrations, similarly rank individuals with respect to 25(OH)D blood concentrations. Objective: The objective was to determine how much variation in serum 25(OH)D concentrations (nmol/L) could be explained by a predictive model with the use of different vitamin D surrogate markers (latitude of residence, mean annual regional solar irradiance estimates, and oral sources) and other individual characteristics that might influence vitamin D status. Design: A random sample of 3055 postmenopausal women (aged 50-70 y) participating in 3 nested case-control studies of the Women's Health Initiative Calcium plus Vitamin D Clinical Trial was used. Serum 25(OH)D values, assessed at year 1 (1995-2000), and potential predictors of 25(OH)D concentrations, assessed at year 1 or Women's Health Initiative baseline (1993-1998), were used. Results: More than half of the women (57.1%) had deficient (<50 nmol/L) concentrations of 25(OH)D. Distributions of 25(OH)D concentrations by level of latitude of residence, mean annual regional solar irradiance, and intake of vitamin D varied considerably. The predictive model for 25(OH)D explained 21% of the variation in 25(OH)D concentrations. After adjustment for month of blood draw, breast cancer status, colorectal cancer status, fracture status, participation in the hormone therapy trial, and randomization to the dietary modification trial, the predictive model included total vitamin D intake from foods and supplements, waist circumference, recreational physical activity, race-ethnicity, regional solar irradiance, and age. Conclusions: Surrogate markers for 25(OH)D concentrations, although somewhat correlated, do not adequately reflect serum vitamin D measures. These markers and predictive models of blood 25(OH)D concentrations should not be given as much weight in epidemiologic studies of cancer risk.

AB - Background: It is unclear how well surrogate markers for vitamin D exposure (eg, oral intake of vitamin D and estimates of sunlight exposure), with and without consideration of other potential predictors of 25-hydroxyvitamin D [25(OH)D] concentrations, similarly rank individuals with respect to 25(OH)D blood concentrations. Objective: The objective was to determine how much variation in serum 25(OH)D concentrations (nmol/L) could be explained by a predictive model with the use of different vitamin D surrogate markers (latitude of residence, mean annual regional solar irradiance estimates, and oral sources) and other individual characteristics that might influence vitamin D status. Design: A random sample of 3055 postmenopausal women (aged 50-70 y) participating in 3 nested case-control studies of the Women's Health Initiative Calcium plus Vitamin D Clinical Trial was used. Serum 25(OH)D values, assessed at year 1 (1995-2000), and potential predictors of 25(OH)D concentrations, assessed at year 1 or Women's Health Initiative baseline (1993-1998), were used. Results: More than half of the women (57.1%) had deficient (<50 nmol/L) concentrations of 25(OH)D. Distributions of 25(OH)D concentrations by level of latitude of residence, mean annual regional solar irradiance, and intake of vitamin D varied considerably. The predictive model for 25(OH)D explained 21% of the variation in 25(OH)D concentrations. After adjustment for month of blood draw, breast cancer status, colorectal cancer status, fracture status, participation in the hormone therapy trial, and randomization to the dietary modification trial, the predictive model included total vitamin D intake from foods and supplements, waist circumference, recreational physical activity, race-ethnicity, regional solar irradiance, and age. Conclusions: Surrogate markers for 25(OH)D concentrations, although somewhat correlated, do not adequately reflect serum vitamin D measures. These markers and predictive models of blood 25(OH)D concentrations should not be given as much weight in epidemiologic studies of cancer risk.

UR - http://www.scopus.com/inward/record.url?scp=77951966509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951966509&partnerID=8YFLogxK

U2 - 10.3945/ajcn.2009.28908

DO - 10.3945/ajcn.2009.28908

M3 - Article

C2 - 20219959

AN - SCOPUS:77951966509

VL - 91

SP - 1324

EP - 1335

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 5

ER -